Detalles de la búsqueda
1.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
NPJ Vaccines;
9(1): 67, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38553525
2.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis;
23(12): 1408-1417, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37544326
3.
Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination.
NPJ Vaccines;
8(1): 39, 2023 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36922512
4.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet;
401(10373): 294-302, 2023 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709074
5.
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
Lancet Infect Dis;
22(8): 1210-1220, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35568049
6.
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
Nat Med;
28(5): 1022-1030, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411076
7.
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial.
Lancet Respir Med;
9(10): 1111-1120, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33864736
8.
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
PLoS One;
14(9): e0222178, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31532789
9.
A proof of concept for structure-based vaccine design targeting RSV in humans.
Science;
365(6452): 505-509, 2019 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31371616
10.
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.
Lancet;
393(10174): 889-898, 2019 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30686586
11.
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
PLoS One;
13(11): e0206837, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30388160
12.
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.
PLoS Med;
15(1): e1002493, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29364886
13.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
Lancet;
391(10120): 552-562, 2018 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29217376
14.
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.
NPJ Vaccines;
2: 15, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29263871
15.
Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses.
Clin Nucl Med;
42(5): 329-334, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28288041
16.
Chimpanzee Adenovirus Vector Ebola Vaccine.
N Engl J Med;
376(10): 928-938, 2017 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25426834
17.
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.
Contemp Clin Trials;
44: 112-118, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275339
18.
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial.
PLoS One;
10(5): e0125914, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25950433
19.
Phase 1 study of pandemic H1 DNA vaccine in healthy adults.
PLoS One;
10(4): e0123969, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884189
20.
Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus.
Hum Vaccin Immunother;
10(12): 3446-54, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25483691